Search results for "FDA update"
Brentuximab gets boxed warning
A boxed warning has been added to lymphoma drug brentuximab vedotin (Adcetris) regarding its association with progressive multifocal leukoencephalopathy (PML).
https://immattersacp.org/weekly/archives/2012/01/24/7.htm
24 Jan 2012
Possibility of mixed drugs from Endo Pharmaceuticals
The FDA recently warned physicians and the public about the possibility of packaging mix-ups of some prescription opiate medications and over-the-counter non-opiate products manufactured and packaged for Endo Pharmaceuticals by Novartis Consumer Health.
https://immattersacp.org/weekly/archives/2012/01/24/8.htm
24 Jan 2012
Generic atorvastatin, middle-of-the-night zolpidem approved
Recalls, warnings, approvals and other regulatory news.
https://immattersacp.org/archives/2012/02/fda.htm
1 Feb 2012
Contraceptive pills recalled
Twenty-eight lots of oral contraceptives have been recalled by manufacturer Pfizer because some blister packs may contain an inexact count of inert or active-ingredient tablets and the tablets may be out of sequence.
https://immattersacp.org/weekly/archives/2012/02/07/6.htm
7 Feb 2012
Proton-pump inhibitors to carry warning about C. diff
The FDA warned last week that proton-pump inhibitors (PPIs) may be associated with an increased risk of Clostridium difficile–associated diarrhea (CDAD).
https://immattersacp.org/weekly/archives/2012/02/14/7.htm
14 Feb 2012
New pneumonia vaccine option for patients over 50
Recalls, warnings, approvals and other regulatory news.
https://immattersacp.org/archives/2012/03/fda.htm
1 Mar 2012
Statin warnings on liver enzymes, blood glucose revised
The warning labels on statin medications are being changed, the FDA announced last week.
https://immattersacp.org/weekly/archives/2012/03/06/7.htm
6 Mar 2012
What makes a misleading ad?
In May 2010, the FDA launched a program designed to help clinicians recognize possible misleading prescription drug promotions and report such promotions to the FDA.
https://immattersacp.org/weekly/archives/2012/03/13/7.htm
13 Mar 2012
Warning on PPIs and C. diff, contraceptive pill mixup
Recalls, warnings, approvals and other regulatory news.
https://immattersacp.org/archives/2012/04/fda.htm
1 Apr 2012
Warning about mixing protease inhibitors with statins
This regulatory update includes a warning on combining protease inhibitors and statins, approval of an orphan drug, and steps the FDA is taking to increase the supply of cancer drugs.
https://immattersacp.org/archives/2012/05/fda.htm
1 May 2012